Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05941637
Status:
AVAILABLE
Last Update Posted:
2023-07-12
First Post:
2023-07-03
Brief Title:
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer Ductal Papillary Chromophobic Oncocytic With Mutations in VHL PBRM1 BAP1 SETD2 VEGF
Sponsor:
Lynkcell Europe
Organization:
Lynkcell Europe
Organization Data
Organization:
Lynkcell Europe
Class:
OTHER
Study ID:
EAR688789-CH
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lynkcell Europe
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None